Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center


Learn More

VICC toll-free number 1-877-936-8422

Clinical Trial VICCHEM1137


MicroRNAs in Myelodysplastic Syndrome

Principal Investigator(s)

Annette Kim


  • Protocol No. VICCHEM1137
  • Open Date: 07/22/2011
  • Staging: N/A
  • Age Group: Adults
  • Scope: National
  • Objective: Determine the contribution of hypermethylation in the dysregulation of miRNA expression in MDS.
  • Disease Sites: None Specified
  • Therapies: Correlative
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University; Jackson-Madison County Hospital; Roswell Park Cancer Institute; Thomas Jefferson University Hospital; The Jones Clinic; Boston Baskin Cancer Group (UTCI)
  • Secondary Protocol No: Not Specified


None Provided.


Not provided. Please call for more information.